-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Satellos Announces First Participant Dosed In Phase 2 Pediatric Study Of Sat-3247 For Duchenne Muscular Dystrophy

Reuters·02/12/2026 12:25:20

Please log in to view news